IMR Press / CEOG / Volume 49 / Issue 2 / DOI: 10.31083/j.ceog4902051
Open Access Original Research
Is ovarian cystectomy feasible for patients with borderline ovarian tumors? A retrospective study and review of the literature
Show Less
1 Department of Obstetrics and Gynecology, CHA Ilsan Medical Center, CHA University School of Medicine, 10414 Gyeonggi-do, Republic of Korea
2 Department of Obstetrics and Gynecology, Korea University College of Medicine, 02841 Seoul, Republic of Korea
*Correspondence: (Jae Yun Song)
Academic Editors: Alessandro Conforti and Michael H. Dahan
Clin. Exp. Obstet. Gynecol. 2022, 49(2), 51;
Submitted: 18 May 2021 | Revised: 29 July 2021 | Accepted: 20 August 2021 | Published: 14 February 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: Given that borderline ovarian tumors (BOTs) are usually found in young, fertile women without a history of childbirth, fertility preservation should be considered in the treatment plan. This retrospective study aimed to evaluate the safety of ovarian cystectomy in patients with BOTs. Methods: Patients with BOTs treated between August 2007 and August 2016 at our institution were divided into two groups according to the type of surgery: the cystectomy group and the oophorectomy group with or without salpingectomy, and differences in surgical outcomes were compared. The cumulative disease recurrence was also compared using Kaplan–Meier curves. Results: Of the 162 patients enrolled, 128 (79.0%) underwent an oophorectomy with or without salpingectomy and 34 (21.0%) underwent an ovarian cystectomy. The patients in the cystectomy group were younger than those in the oophorectomy group (29.2 years vs. 46.5 years, p < 0.001), and the proportion of patients who underwent minimally invasive surgery was higher in the cystectomy group than in the oophorectomy group (88.2% vs. 46.9%, p < 0.001). During the mean follow-up period of 44 months, six patients (3.70%) developed disease recurrence (five [3.9%] and one [2.9%] in the oophorectomy and cystectomy groups, respectively). The two-year disease-free survival rate was 97.1% and 97.6% in the cystectomy and oophorectomy groups, respectively, and did not differ between the groups (p = 0.818). Discussion: Ovarian cystectomy can be considered a safe and effective option for young women with BOTs who wish to preserve their fertility.

Borderline ovarian tumor
Fertility sparing
Ovarian cystectomy
Fig. 1.
Back to top